Financials
- Market Capitalization 27.17 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.98
Relación precio/flujo de caja
12.37
Dividendos por acción
0.47
Rendimiento por dividendo, %
4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 351 | RVMD Revolution Medicines, Inc. - Common Stock | 207.88 USD | -6.00% | +0.47% | +12.71% | +275.23% | 44.56 B USD | ||
| 445 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 241.00 USD | +1.64% | +3.46% | +15.84% | -45.94% | 32.25 B USD | ||
| 504 | INSM Insmed Incorporated - Common Stock | 120.19 USD | +1.39% | -4.69% | +22.39% | -25.83% | 26.25 B USD | ||
| 513 | INCY Incyte Corporation - Common Stock | 122.69 USD | -1.35% | -3.83% | +2.05% | +44.39% | 24.87 B USD |